RE:Potential New CXR PartnerGoodman from Knight already talked about this on one of the last conference calls. He said he figured there would be a fire sale early next year and has the cash ready to deploy to pick the bones. He alluded to companies who overpaid and overleveraged for weak assets and figured they would collapse before too long. He didn't specifically mention cxr, but they certainly fit the profile. He is one of the smartest operators in the industry and this confirmed my thesis that there is a good possibility this equity could be worth zero.
Lumberfeverlong wrote: I have been trying to figure out who would be a good partner for CXR from a merger or cross-marketing perspective. I think Knight Therapeutics would make a good parner. Good portfolio of proproietary or licensed drugs and loads of cash with limited international distribution network. Any thoughts?